Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Iktos S.A.S.

Headquarters: Paris, France
Year Founded: 2016
Status: Private

BioCentury | Jun 25, 2024
Deals

Deals Report: Roche licenses Ascidian’s RNA editing tech for neuro

Plus: Day One adds PTK7 ADC from MabCare, and updates from Sanofi-Belharra and more
BioCentury | May 4, 2024
Management Tracks

CFOs depart Vir, Cellectis

Plus: Lykos names CCO, VP, and an update from Iktos
BioCentury | Jan 19, 2024
Management Tracks

GSK vet McLoughlin joins HilleVax as COO

Plus: Acadia alum Stankovic passes away and updates for AZ, Immunitas, Iktos, Certis and PepGen
BioCentury | Mar 10, 2023
Regulation

March 10 Quick Takes: FDA approves Pfizer’s nasal spray for migraine

Plus: $50M series B, new CMO for cross-border play Allorion and updates from Merck & Co., Intercept, Iktos and more
Items per page:
1 - 4 of 4